Sepsis-associated cholestasis in adult patients: A prospective study

American Journal of the Medical Sciences

Volumn 346, Issue 6, 2013, Pages 462-466

  Fan, He Bin ^a   Yang, Dong Liang ^b   Chen, An Shen ^a   Li, Zhi ^a   Xu, Li Tong ^a   Ma, Xiao Ju ^a   Zhou, Hao ^a   Tian, Zhan Fei ^a   Wu, Juan Juan ^a   Yan, Fu Ming ^a  

^a The People's Liberation Army 161 Hospital   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

APACHE II; Cholestasis; Sepsis; SOFA

Indexed keywords

ANTIINFECTIVE AGENT;

ACINETOBACTER; ADULT; APACHE; ARTICLE; BACTEREMIA; BLOODBORNE BACTERIUM; CHOLESTASIS; CLINICAL ASSESSMENT; COMPARATIVE STUDY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FEMALE; HEPATOBILIARY SYSTEM INFECTION; HOSPITALIZATION; HUMAN; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OBSERVATIONAL STUDY; ORGAN DYSFUNCTION SCORE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SEPSIS; SEPSIS ASSOCIATED CHOLESTASIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTION;

EID: 84890860984     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3182955457     Document Type: Article

References (29)

1. Trauner M, Fickert P, Stauber RE. Inflammation-induced cholestasis. J Gastroenterol Hepatol 1999;14:946-59
2. Rooney JC, Hill DJ, Danks DM. Jaundice associated with bacterial infection in the newborn. Am J Dis Child 1971;122:39-41
3. Chand N, Sanyal AJ. Sepsis-induced cholestasis. Hepatology 2007;45: 230-41
4. Moseley RH. Sepsis and cholestasis. Clin Liver Dis 2004;8:83-94
5. Fuchs M, Sanyal AJ. Sepsis and cholestasis. Clin Liver Dis 2008;12: 151-72
6. Kosters A, Karpen SJ. The role of inflammation in cholestasis: Clinical and basic aspects. Semin Liver Dis 2010;30:186-94
7. Cardoso FL, Kittel A, Veszelka S, et al. Exposure to lipopolysaccharide and/or unconjugated bilirubin impair the integrity and function of brain microvascular endothelial cells. PLoS One 2012;7:e35919
8. Shimizu K, Ogura H, Hamasaki T, et al. Altered gut flora are associated with septic complications and death in critically ill patients with systemic inflammatory response syndrome. Dig Dis Sci 2011;56:1171-7
9. Marshall JC, Foster D, Vincent JL, et al. Diagnostic and prognostic implications of endotoxemia in critical illness: Results of the MEDIC study. J Infect Dis 2004;190:527-34
10. Funada H, Matsuda T, Okada Y. Jaundice associated with Pseudomonas aeruginosa bacteremia complicating acute leukemia. Intern Med 1995;34:100-3
11. Humble MW, Eykyn S, Phillips I. Staphylococcal bacteraemia, fusidic acid, and jaundice. Br Med J 1980;280:1495-8
12. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: A severity disease classification system. Crit Care Med 1985;13:818-29
13. Vincent JL, Moreno R, Takala J, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22: 707-10
14. AI-Shamahy HA, Sabrah AA, AI-Robasi AB, et al. Types of bacteria associated with neonatal sepsis in Al-Thawra University Hospital, Sana'a, Yemen, and their antimicrobial profile. Sultan Qaboos Univ Med J 2012; 12:48-54
15. Shapiro NI, Arnold R, Sherwin R, et al. The association of nearinfrared spectroscopy-derived tissue oxygenation measurements with sepsis syndromes, organ dysfunction and mortality in emergency department patients with sepsis. Crit Care 2011;15:R223
16. Gordon AL, English M, Tumaini Dzombo J, et al. Neurological and developmental outcome of neonatal jaundice and sepsis in rural Kenya. Trop Med Int Health 2005;10:1114-20
17. Kenzaka T, Okayama M, Kuroki S, et al. Use of a semiquantitative procalcitonin kit for evaluating severity and predicting mortality in patients with sepsis. Int J Gen Med 2012;5:483-8
18. Umgelter A, Reindl W, Lutz J, et al. Treatment of septic patients with an arginine-based endotoxin adsorber column improves hemodynamics and reduces oxidative stress: Results of a feasibility study. Blood Purif 2008;26:333-9
19. Shah AA, Patton M, Chishty WH, et al. Analysis of elevated liver enzymes in an acute medical setting: Jaundice may indicate increased survival in elderly patients with bacterial sepsis. Saudi J Gastroenterol 2010;16:260-3
20. Khalil S, Shah D, Faridi MM, et al. Prevalence and outcome of hepatobiliary dysfunction in neonatal septicaemia. J Pediatr Gastroenterol Nutr 2012;54:218-22
21. Watanakunakorn C, Chan SJ, Demarco DG, et al. Staphylococcus aureus bacteremia: Significance of hyperbilirubinemia. Scand J Infect Dis 1987;19:195-203
22. Famularo G, De Simono C, Nicotra GC. Jaundice and the sepsis syndrome: A neglected link. Eur J Intern Med 2003;14:269-71
23. Quale JM, Mandel LJ, Bergasa NV, et al. Clinical significance and pathogenesis of hyperbilirubinemia associated with Staphylococcus aureus septicemia. Am J Med 1988;85:615-8
24. Franson TR, Hierholzer WJ Jr, Labrecque DR. Frequency and characteristics of hyperbilirubinemia associated with bacteremia. Rev Infect Dis 1985;7:1-9
25. Geier A, Fickert P, Trauner M. Mechanisms of disease: Mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastroenterol Hepatol 2006;3:574-85
26. Valenza F, Fagnani L, Coppola S, et al. Prevalence of endotoxemia after surgery and its association with ICU length of stay. Crit Care 2009;13:R102
27. Zhai R, Sheu CC, Su L, et al. Serum bilirubin levels on ICU admission are associated with ARDS development and mortality in sepsis. Thorax 2009;64:784-90
28. Narita R, Murata M, Kihara Y, et al. Sepsis presenting with severe jaundice. Am J Gastroenterol 2001;96:3214-5
29. Ueno T, Sugino M, Nemoto H, et al. Effect over time of endotoxin adsorption therapy in sepsis. Ther Apher Dial 2005;9:128-36